S

Spruce Biosciences
D

SPRB

0.52750
USD
0.00
(0.84%)
مغلق
حجم التداول
41
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
21,787,121
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Spruce Biosciences

القطاع: Healthcare
الصناعة: Biotechnology
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).